A prospective trial on the prevalence and the variation over time of SARS-CoV-2 antibodies in hospital health care workers (COVID-19)

A prospective trial on the prevalence and the variation over time of SARS-CoV-2 antibodies in hospital health care workers (COVID-19) - COWUPAK

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021729

Enrollment

300

Registered

2020-05-25

Start date

2020-05-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1 COVID-19

Interventions

Group 1: HCW in COVID-19 risk areas (i.e. wards with COVID-19 patients, emergency room) Group 2: HCW that have been tested positive for SARS-CoV-2 Group 3: Control group, HCW without known profession

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: employee of Helios Universitätsklinikum Wuppertal

Exclusion criteria

Exclusion criteria: missing informed consent

Design outcomes

Secondary

Measure	Time frame
Determination of the antibody values over time in a smaller group of participants.	—

Primary

Measure	Time frame
Determination of SARS-CoV-2 antibodies in HCW with and without former positive SARS-CoV-2 PCR at time of inclusion in our study. Determination of the respective prevalence.	—

Countries

Germany

Contacts

Public ContactFelix Giebel

Helios Universitätsklinikum Wuppertal

felix.giebel@helios-gesundheit.de0202-896-2729

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026